Advertisement

Lumbini General Insurance Co. Ltd. (LGIL)

Non-Life Insurance · Rs. 509.90 -22.10 (-4.15%) as of Mar 12, 2023

Price — last 6 months

Full chart →
Open
529.90
High / Low
529.90 / 488.00
Prev. close
532.00
Volume
86,177
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding—
Public holding—

Stock performance

1-week change
+4.06%
1-month change
-4.12%
3-month change
+42.81%
6-month change
+42.81%
YTD change
+42.81%
1-year change
-10.84%
1-month high
536.00
1-month low
481.20
From 52-week high
—
From 52-week low
—
180-day avg price
500.52
360-day avg price
479.38
Avg volume (1w)
39,522
Avg volume (1m)
17,596
Avg volume (6m)
30,351
Avg volume (12m)
16,318
Daily volatility (1m)
2.59%
Beta vs NEPSE (1y)
—

Valuation

EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Non-Life Insurance

EPS (Rs.)
N/A
min —avg —max —
—
P/E
N/A
min —avg —max —
—
P/B
N/A
min —avg —max —
—
Networth / Share (Rs.)
N/A
min —avg —max —
—
ROE (%)
N/A
min —avg —max —
—

Technical indicators

RSI (14)57.40Neutral
MACD16.48Bearish
EMA 5509.15Bullish
EMA 20496.39Bullish
EMA 180512.64Bearish
SMA 50435.47Bullish
SMA 200541.06Bearish
Pivot levels (classic)
S3
446.73
S2
467.37
S1
488.63
PP
509.27
R1
530.53
R2
551.17
R3
572.43

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Non-Life Insurance stocks

LGIL — frequently asked questions

What is Lumbini General Insurance Co. Ltd.'s share price?

Rs. 509.90 as of Mar 12, 2023, the latest NEPSE trading session (-4.15% on the day).

What dividend did LGIL pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.